Encyclopedia

bile acid

Also found in: Dictionary, Medical, Acronyms, Wikipedia.

bile acid

[′bīl ′as·əd]
(biochemistry)
Any of the liver-produced steroid acids, such as taurocholic acid and glycocholic acid, that appear in the bile as sodium salts.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
Mentioned in
References in periodicals archive
In each case, 1 [beta]g of each bile acid sulfate was incubated with 10 mL sodium acetate buffer (0.05 M, pH 4.6 or 6.2) and enzyme (0.1 mL) at 37[degrees]C overnight in a shaking water bath.
Bioassays of total cholesterol and bile acids in the feces
Selective oxidations and acylations in the bile acid series," Journal of the American Chemical Society, vol.
The term ICP was used if the serum bile acid level was [greater than or equal to]10 [micro]mol/L with pruritus that could not be explained by any other condition.
BASD accounts for about 2% of neonatal cholestasis cases, and early primary bile acid replacement treatment can achieve good results.
(8,12) Finally, cholesterol is transformed into bile acid and efflux outside of the body, which is also an important cholesterol-eliminating way and the transformation is mainly controlled by cholesterol 7alpha-hydroxylase (CYP7A1).
Albireo Pharma is a clinical-stage biopharmaceutical company focused through its operating subsidiary on the development of novel bile acid modulators to treat orphan pediatric liver diseases, and other liver and gastrointestinal diseases and disorders.
The condition causes the build-up of bile acids in the blood, and symptoms include itching, often severe.
According to the company, Maralixibat is an inhibitor of the apical sodium-dependent bile acid transporter (ASBT), which recycles bile acids from the intestine to the liver.
Bile acid malabsorption can cause diarrhea or loose stools.
Albireo Pharma announced that clinical data from a Phase 2 study of lead product candidate odevixibat or A4250, a highly potent and selective inhibitor of the ileal bile acid transporter, IBAT, in biliary atresia, Alagille syndrome and progressive familial intrahepatic cholestasis, PFIC, were presented today at the 2019 European Society for Paediatric Gastroenterology, Hepatology and Nutrition Annual Meeting in Glasgow, Scotland.
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.